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Abstract 
 
A number of oral disorders have been associated with Diabetes mellitus (DM) such as: periodontal diseases, dental caries, 
salivary dysfunctions, oral mucosal diseases, oral infections such as candidiasis, taste and other neurosensory disorders. 
This article would discuss about the advances in understanding the relationship between oral diseases and systemic 
conditions need to be translated into clinical practice. Dentist should be active in the involvement in office management of 
patient with type 1 or type 2 DM. Patients with long-standing, poorly controlled DM are at risk of developing oral 
candidiasis, and the evidence indicates that periodontitis is a risk factor for poor glycemic control and the development of 
other clinical complications of DM. DM is a disease of which the general public and practicing dentists should be aware. 
On the basis of the available data, we can conclude that practicing dentists can have a significant, positive effect on the 
oral and general health of patients with DM. Since higher population is thought to have DM, a greater role for the oral 
health care team in the management of the care of patients with DM is both warranted and appropriate. In conclusion, 
dentists need to be involved in the prevention and management of DM to improve the treatment of oral disease. By active 
intervening to identify and monitor patients with DM, dentists have an opportunity to improve patients’ oral and systemic 
health. 
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Abstrak 
 
Sejumlah kelainan didalam mulut berhubungan dengan Diabetes Mellitus (DM) seperti: penyakit periodontal, karies, 
disfungsi air liur, muklosa mulut, kandidiasis, rasa dan gangguan sensor syaraf. Tulisan ini akan membahas tentang 
kemajuan dalam pemahaman hubungan antara penyakit gigi dan kondisi sistematik yang perlu diperhatikan dalam 
praktek di klinik. Dokter gigi harus aktif terlibat dalam penatalaksanaan pasien DM tipe 1 atau 2. Pasien dengan kontrol 
DM yang buruk mempunyai resiko untuk mengalami kandidiasis dan bukti menunjukkan penyakit periodontitis 
diakibatkan kontrol  kadar gula yang buruk dan menyebabkan komplikasi klinik lainnya. DM merupakan penyakit yang 
mana Masyarakat umum dan Dokter gigi harus menyadari. Berdasarkan data yang ada, dapat disimpulkan bahwa Dokter 
gigi yang praktek mempunyai pengaruh yang positif dan bermakna pada kesehatan mulut dan umum pasien DM, karena 
jumlah masyarakat meningkat, peranan tim kesehatan mulut perlu menangani pasien DM dengan tepat, walaupunbanyak 
aspek dari komponen baru ini dari praktek gigi perlu dikembangkan, suatu kesempatan pada profesi gigi untuk bersatu. 
Kesimpulannya, dokter gigi perlu terlibat dalam pencegahan dan penatalaksanaan DM untuk meningkatkan perawatan 
penyakit gigi dan mulut, dengan menginterpensi secara aktif dalam mengidentifikasi dan memotivasi pasien DM, dokter 
gigi mempunyai kesempatan untuk meningkatkan kesehatan gigi dan mulut pasien. 
 
Kata kunci: Diabetes mellitus, praktek gigi, penatalaksanaan klinik 
 
 
INTRODUCTION  
 
   The number of people with diabetes will be double 
worldwide by 2030, according to new estimates 
from researchers at the World Health Organization 
(WHO) and several European universities. In a 
survey conducted by WHO, Indonesia was ranked 
the 4th largest in the world.
1
 International Diabetes 
Federation (IDF), which is sponsored by the World 
Diabetes Foundation, also conducts surveys about 
the number of diabetics in a country. In the book 
Diabetes Atlas Executive Summary, the 2nd edition,  
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Indonesia was ranked the 3rd largest in the world.  
   Furthermore, approximately 30 percent of people 
with diabetes mellitus have undiagnosed diabetes 
mellitus. Therefore, the dental office is a health care 
site that can help identify undiagnosed diabetes 
mellitus, which can lead to better management of 
the care of patients with diabetes.  
 
Table 1. List of countries with the highest numbers of 
estimated cases of diabetes for year 2000 and  
2030 (1) 
 
  Year of 2000 Year of 2030 
 
Rank Country People with 
diabetes 
(millions) 
Country People with 
diabetes   
(millions) 
 
 
1 
 
India 
 
31.7 
 
India 
 
79.4 
2 China 20.8 China 42.3 
3 U.S. 17.7 U.S. 30.3 
4 Indonesia 8.4 Indonesia 21.3 
5 Japan 6.8 Pakistan 13.9 
6 Pakistan 5.2 Brazil 11.3 
7 Russian 
Federation 
4.6 Bangladesh 11.1 
8 Brazil 4.6 Japan 8.9 
9 Italy 4.3 Philippines 7.8 
10 Bangladesh 3.2 Egypt 6.7 
 
 
      The term "Diabetes mellitus" (DM) is used         
to  identify  a  group  of  disorders   characterized  by  
elevated level of glucose in blood. This elevation  is  
the result of a deficiency in insulin secretion or an 
increased cellular resistance to the actions of insulin, 
leading to a variety of metabolic abnormalities in-
volving carbohydrates, fats and proteins. In healthy 
people, blood glucose levels usually are maintained 
within a range of 60 to 150 mg/dL, throughout the 
day. Insulin serves a critical role in the regulation of 
blood glucose.
2
 It is synthesized in the beta cells of 
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excessive urination (polyuria) occurs because of 
osmotic diuresis. Increased fluid loss leads to dehy-
dration and excessive thirst (polydipsia). Since cells 
are starved of glucose, the patient experiences in-
creased hunger (polyphagia). Paradoxically, the dia-
betic patient often loses weight, since the cells are 
unable to take up glucose.
2
 
   A number of pathological mechanisms related to 
elevated levels of glucose in the blood have been 
defined, including the activation of the sorbitol 
pathway, the formation of advanced glycation end-
products (AGEs), the damaging effect of oxidative 
stress and altered lipid metabolism. These mecha-
nisms have been associated with classical clinical 
complications of DM such as an increased incidence 
of both microvascular and macrovascular complica-
tions.
2,4
 Long-term sequelae of DM may include 
retinopathy, with potential loss of vision, and ne-
phropathy leading to renal failure. Hypertension, 
hyperlipidemia, atherosclerotic cardiovascular disea-
se, peripheral vascular disease and cerebrovascular 
disease also are common. Some patients experience 
peripheral and autonomic neuropathies such as 
numbness and tingling of extremities, oral pares-
thesia and burning. People with poorly controlled 
DM also may have impaired wound healing and 
increased susceptibility to infections. Among the 
mechanisms thought to produce the tissue damage 
associated with chronic hyperglycemia are glycation 
of tissue proteins and excess production of polyol 
compounds from glucose.
3
  
 
DIAGNOSIS 
 
Several glucose tests could be used to diagnose DM 
such as: 
1. Casual plasma glucose level (taken at any time 
of day) of 200 mg/dL (11.1 millimolar) or grea-
ter when the classical symptoms of diabetes are 
present (polydipsia, polyuria and unex-plained 
weight loss).  
2. Fasting plasma glucose level of 126 mg/dL   
(7.0 mmol/L) or greater.  
3. Oral glucose tolerance test value in blood of 
200 mg/dL or greater when measured at the 
two-hour interval.  
   These criteria are expected to lead to a further in-
crease in the number of patients diagnosed who had 
DM. The normal fasting plasma glucose level is 
now defined as less than 110 mg/dL. Included in the 
current classification system are the terms “impaired 
glucose tolerance,” or IGT, and “impaired fasting 
glucose,” or IFG, which refer to a metabolic stage 
between the stages of normal glucose homeostasis 
and DM. This stage includes people with fasting 
plasma glucose levels of 110 mg/dL or greater but 
less than 126 mg/dL.  
   Because early detection and prompt treatment may 
reduce the burden and complications of type 2 DM, 
the American Diabetes Association recommends 
that all people older than age 45 years are screened 
every three years, and that screening should be 
earlier and more frequent in high-risk people, in-
cluding those with previously identified IGT or 
IFG.
7
 
 
Table 3.  Diagnostic Criteria for Diabetes Mellitus and 
Impaired Glucose Regulation  
 
Test  Normal  Impaired Glucose Re-
gulation  
 
Diabetes  
 
FPG 
 
< 100 (< 5.6) 
 
100–125 (5.6–6.9) 
 
≥ 126 (≥ 7.0) 
 
OGTT 
 
< 140 (< 7.7) 
 
140–199 (7.7–11.0) 
 
≥ 200 (≥ 11.1) 
 
FPG = fasting plasma glucose; OGTT = oral glucose tolerance test,    
2 h glucose level. 
Note: All values refer to glucose levels in mg/dL [mmol/L]. 
 
MEDICAL MANAGEMENT 
 
   The objective of medical management in all 
patients with DM is to maintain blood glucose levels 
as close to normal as possible. It is proven that good 
glycemic control inhibits the onset and delays the 
progression of complications of type 1 DM and  
evidence indicates a similar relationship for type 2 
DM.
3,4
 
   The glycated hemoglobin assay (HbA1c) reflects 
mean glycemia levels over the preceding two to 
three months, and currently is used to assess 
whether a patient’s metabolic control has remained 
within the target range (normal value <7 percent). 
The glycated hemoglobin value also has been 
shown to be a predictor for the development of 
chronic complications in patients with DM. Inten-
sive treatment programs and comprehensive educa-
tion in self-management, including diet control, 
exercise and frequent self-monitoring of blood glu-
cose levels are essential components of disease 
management.
8
 
1. Insulin 
 Insulin is used in the medical management of all 
patients with type 1 DM and in some patients 
with type 2 DM. It is available in rapid-, short-, 
inter-mediate and longacting forms that usually 
are administered by patient via subcutaneous 
injecttion. Alternatively, continuous subcutane-
ous insulin infusion by means of a computeri-
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dental treatment and immediately administer 15 
grams of a fast-acting oral carbohydrate such as 
glucose tablets or gel, sugar, candy, soft drinks or 
juice. It is important to note that the α-glucosidase 
inhibitors prevent the hydrolysis of sucrose into 
fructose and glucose. Therefore, a hypoglycemic 
episode in a patient taking these drugs should be 
treated with a direct source of glucose. After im-
mediate treatment, dentists should measure blood 
glucose levels to confirm the diagnosis and deter-
mine if repeated carbohydrate dosing is needed. If 
patient is unable to swallow or lose consciousness, 
the dentist should seek medical assistance; 25 to 30 
mL of a 50 percent dextrose solution or 1 mg of 
glucagon should be administered intravenously. 
Glucagon also can be injected subcutaneously or 
intramuscularly.
3
 
         Severe hyperglycemia associated with type 1 
ketoacidosis or type 2 hyperosmolar nonketotic 
states usually has a prolonged onset. Therefore, the 
risk of a hyperglycemic crisis is much lower than 
that of a hypoglycemic crisis in a dental practice 
setting. Ketoacidosis may develop, with nausea, 
vomiting, abdominal pain and an acetone odor. 
Definitive management of hyperglycemia requires 
medical intervention and insulin administration. 
However, it may be difficult to differentiate between 
hypoglycemia and hyperglycemia based on sym-
ptoms alone. Therefore, the dentist should adminis-
ter a carbohydrate source to a patient in whom a 
presumptive diagnosis of hypoglycemia is made. 
Even if patient undergoes a hyperglycemic episode, 
the small amount of additional sugar is unlikely to 
cause significant harm.
2
 The clinician should mea-
sure blood glucose levels after immediate treatment. 
8. Post treatment 
 Clinicians should keep in mind these post-
operative considerations. Patients with poorly 
controlled DM are at greater risk of developing 
infections and may demonstrate delayed wound 
healing
3
. Acute infection can be adversely affect 
insulin resistance and glycemic control, which, 
in turn, may further affect the body’s capacity 
for healing.  
   Therefore, antibiotic coverage may be necessary 
for patients with overt oral infections or for those 
underwent extensive surgical procedures
4
. If the 
dentist anticipates that normal dietary intake will be 
affect-ted after treatment, insulin or oral anti-
diabetic medication dosages may need to be 
appropriately adjusted in consultation on patient’s 
physician. Salicylates increase insulin secretion and 
sensitivity and can potentiate the effects of sul-
fonylureas, resulting in hypoglycemia. Therefore, 
aspirin and aspirin-containing compounds generally 
should be avoided for patients with DM.
9
 
   A number of oral disorders have been associated 
with diabetes mellitus.
11
 The association of diabetes 
mellitus and periodontal diseases (such as gingivitis 
and periodontitis) has received the greatest attention 
and is the focus of this article.
12,13
 In addition to 
gingivitis and periodontitis, Fortune listed dental 
caries, salivary dysfunction, oral mucosal diseases, 
oral infections such as candidiasis, taste and other 
neurosensory disorders.
4
  
 
DISCUSSION 
 
   The results of study indicated that most GPDs 
reported a lack of confidence in their ability to 
screen patients for Diabetes mellitus, viewed active 
management of care of patients with Diabetes mel-
litus as peripheral to their role as health care pro-
fessionals and thought that their colleagues and 
patients did not expect them to perform such acti-
vities
10
. When the types of activities GPDs actually 
perform was explored, the practitioners reported 
performing more assessment and advising activities 
than active management activities.  
   In a subsequent study, the researchers compared 
the attitudes and behaviors of GPDs and perio-
dontists in diabetes patients
10
. Periodontists were 
chosen as the comparative group because diabetes is 
the most important risk factors for periodontitis.  
Although periodontists tended to identify risk and 
management behaviors for patients who have Dia-
betes mellitus more frequently than did GPDs, both 
groups of dentists tended more to engage in acti-
vities that could be classified as inquiring and dis-
cussing, as opposed to actively managing these risk 
factors. Researchers found that proactive manage-
ment of the care of patients was not performed 
routinely.
12
  
   In case of undiagnosed diabetic person, history of 
signs or symptoms of diabetes or its complication 
should be taken. High risk factors for developing 
diabetes are parents who are diabetic, gave birth to 
one or more large babies, history of spontaneous 
abortions or stillbirth, obese and over 40 years of 
age. If dentist found history of signs or symptoms of 
diabetes and high risk factors detected, referral or 
screening test for diabetes should be made
3
. Dia-
betes mellitus is a disease of which the general 
public and practicing dentists should be aware.  
   We can conclude that practicing dentists and 
dental hygienists can have a significant, positive 
effect on the oral and general health of patients with 
DM. Since approximately eight percent of the 
Indonesian population is thought to have DM, 
prevalence increases with age, and our population is 
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